Aralez Pharmaceuticals unveils new office in Ireland
2nd February 2017
Aralez Pharmaceuticals, a global specialty pharmaceutical company, today announced the opening of new offices in Dublin, Ireland. The company, which focuses on cardiovascular, pain and other specialty areas, plans to add more highly skilled jobs in Dublin by the end of 2017. Adrian Adams, Chief Executive Officer of Aralez Pharmaceuticals, was joined by Mary Mitchell O’Connor, Minister for Jobs, Enterprise and Innovation, to officiate at the opening ceremony. The Dublin offices are Aralez’s first permanent business premises outside of North America.
Speaking at the event, Ms. Mitchell O’Connor said, “The pharma industry makes a huge contribution to the Irish economy in terms of jobs and manufacturing exports, and is one of our fastest growing sectors. In addition to the very big players, we are very keen to attract specialty pharma companies like Aralez who will broaden the reach of the industry here and generate new opportunities. This company's decision to establish its new offices here in Dublin, with quality jobs being created, will help drive the company's expansion into EU markets. I look forward to a mutually beneficial partnership developing".
“The opening of our new Ireland headquarters is extremely important to Aralez. Ireland has an excellent reputation as a leading location for talented professionals in the pharmaceutical industry and will be essential to help us grow our operations over the next few years.”
Welcoming today’s announcement Martin Shanahan, Chief Executive Officer of Ireland’s Industrial Development Authority said: “Ireland is a globally recognised centre of excellence in life sciences due to the country’s strong regulatory track record and talent availability. The pharma industry makes a huge contribution to the Irish economy in terms of the creation of skilled and highly sought after positions. The establishment of Aralez in Dublin represents a welcome endorsement of the talent and business infrastructure which Ireland has to offer. The IDA looks forward to the further growth of Aralez over the course of the next few years.”
